Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Eli Lilly and Company
Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene
May 9th, 2009
Eli Lilly and Company (NYSE:LLY) announced that the U.S. District Court for the Southern District of Indiana issued a preliminary injunction to prevent the launch of a generic version of Lilly's medicine Evista(R) (raloxifene HCl tablets) by Teva Pharmaceuticals until the Court renders its final ruling. Teva had indicated it was prepared to launch the generic version prior to the resolution of outstanding patent litigation currently being considered by the U.S. District Court for the Southern District of Indiana. Lilly had previously sought and been granted a temporary restraining order to prevent the generic launch. "We appreciate the Court issuing a preliminary...
Source: Law & Health Weekly (2009-05-09)
|
